Roche's Alzheimer's Drug Fails to Shine at Phase III | Inside Precision Medicine

Retrieved on: 2022-11-14 21:47:01

Tags for this article:

Click the tags to see associated articles and topics

Roche's Alzheimer's Drug Fails to Shine at Phase III | Inside Precision Medicine. View article details on hiswai:

Excerpt

Roche's early Alzheimer's disease drug candidate gantenerumab fails to meet its primary endpoint in two phase III trials.

Article found on: www.insideprecisionmedicine.com